StreptInCor: A Candidate Vaccine Epitope against S. pyogenes Infections Induces Protection in Outbred Mice

Imagem de Miniatura
Arquivos
art_POSTOL_StreptInCor_A_Candidate_Vaccine_Epitope_against_S_pyogenes_2013.PDF (160.67 KB)
Citações na Scopus
37
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
HIGA, Fabio T.
Citação
PLOS ONE, v.8, n.4, article ID e60969, 6p, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Infection with Streptococcus pyogenes (S. pyogenes) can result in several diseases, particularly in children. S. pyogenes M protein is the major virulence factor, and certain regions of its N-terminus can trigger autoimmune sequelae such as rheumatic fever in susceptible individuals with untreated group A streptococcal pharyngitis. In a previous study, we utilized a large panel of human peripheral blood cells to define the C-terminal protective epitope StreptInCor (medical identity), which does not induce autoimmune reactions. We recently confirmed the results in HLA-transgenic mice. In the present study, we extended the experimental assays to outbred animals (Swiss mice). Herein, we demonstrate high titers of StreptInCor-specific antibodies, as well as appropriate T-cell immune responses. No cross-reaction to cardiac myosin was detected. Additionally, immunized Swiss mice exhibited 87% survival one month after challenge with S. pyogenes. In conclusion, the data presented herein reinforce previous results in humans and animals and further emphasize that StreptInCor could be an effective and safe vaccine for the prevention of S. pyogenes infections.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/1729
Referências
  1. Batzloff MR, 2005, J INFECT DIS, V192, P1450, DOI 10.1086/466528
  2. BESSEN D, 1988, J EXP MED, V167, P1945, DOI 10.1084/jem.167.6.1945
  3. Bisno AL, 2005, CLIN INFECT DIS, V41, P1150, DOI 10.1086/444505
  4. Bronze MS, 2010, AM J MED SCI, V340, P218, DOI 10.1097/MAJ.0b013e3181e939ab
  5. Brook I, 2007, INT J PEDIATR OTORHI, V71, P1501, DOI 10.1016/j.ijporl.2007.06.006
  6. Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X
  7. Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000
  8. Cunningham MW, 2004, MOL IMMUNOL, V40, P1121, DOI 10.1016/j.milimm.2003.11.023
  9. Cunningham MW, 2001, AM J PATHOL, V159, P5, DOI 10.1016/S0002-9440(10)61665-3
  10. DAJANI A, 1995, PEDIATRICS, V96, P758
  11. Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005
  12. Danchin MH, 2007, PEDIATRICS, V120, P950, DOI 10.1542/peds.2006-3368
  13. Fae KC, 2006, J IMMUNOL, V176, P5662
  14. FISCHETTI VA, 1991, SCI AM, V264, P58
  15. Guerino MT, 2011, VACCINE, V29, P8250, DOI 10.1016/j.vaccine.2011.08.113
  16. Guilherme L, 2010, J CLIN IMMUNOL, V30, P17, DOI 10.1007/s10875-009-9332-6
  17. Guilherme L, 2006, CLIN DEV IMMUNOL, V13, P125, DOI 10.1080/17402520600877026
  18. Guilherme L, 2011, J BIOL CHEM, V286, P6989, DOI 10.1074/jbc.M110.132118
  19. Guilherme L, 2011, Ann Pediatr Cardiol, V4, P13, DOI 10.4103/0974-2069.79617
  20. Guilherme L, 2009, METHODS, V49, P316, DOI 10.1016/j.ymeth.2009.03.024
  21. Guilherme L, 2011, ADV CLIN CHEM, V53, P31, DOI 10.1016/S0065-2423(11)53002-1
  22. Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x
  23. Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926
  24. Kotloff KL, 2005, INFECT IMMUN, V73, P2360, DOI 10.1128/IAI.73.4.2360-2366.2005
  25. Kotloff KL, 2004, JAMA-J AM MED ASSOC, V292, P709, DOI 10.1001/jama.292.6.709
  26. Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.1440-1711.2004.01286.x
  27. Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338
  28. McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458
  29. Olive C, 2005, VACCINE, V23, P2298, DOI 10.1016/j.vaccine.2005.01.041
  30. Olive C, 2007, VACCINE, V25, P1789, DOI 10.1016/j.vaccine.2006.11.031
  31. O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264
  32. Pfoh E, 2008, PEDIATRICS, V121, P229, DOI 10.1542/peds.2007-0484
  33. Quinn A, 1998, INFECT IMMUN, V66, P4418
  34. Smeesters PR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000010
  35. Smeesters PR, 2008, VACCINE, V26, P5835, DOI 10.1016/j.vaccine.2008.08.037
  36. Sociedade Brasileira de Cardiologia, 2009, ARQ BRAS CARDIOL S4, V93, P3
  37. Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001
  38. Vohra H, 2005, RES MICROBIOL, V156, P575, DOI 10.1016/j.resmic.2004.12.009

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/19